Ippei Miyata

Ippei Miyata

Auto-generated profile, based on publicly available information

Ippei Miyata

Department of Pediatrics, Kawasaki Medical School, Okayama, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Emerging Infectious Diseases
Verified
Journal Article
Open access
TTTakaaki Tanaka
Takaaki Tanaka
Tomohiro OishiTomohiro Oishi
Tomohiro Oishi
IMIppei Miyata
Ippei Miyata
SWShoko Wakabayashi
Shoko Wakabayashi
MKMina Kono
Mina Kono
KOKazunobu Ouchi
Kazunobu Ouchi
We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008–2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The prevalence of macrolide-resistant M. pneumoniae among children in Japan has decreased.

1 March 2013 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
KSKensuke Shoji
Kensuke Shoji
HKHisako Komuro
Hisako Komuro
IMIppei Miyata
Ippei Miyata
IMIsao Miyairi
Isao Miyairi
ASAkihiko Saitoh
Akihiko Saitoh
Background: Human parechovirus type 3 (HPeV3) infection can cause sepsis-like syndrome and meningoencephalitis in neonates and young infants. Although maculopapular rash is a reported clinical manifestation of HPeV3 infection, the frequency and detailed characteristics of rash in neonates and young infants with HPeV3 infection are unknown. Methods: We retrospectively reviewed the clinical characteristics of neonates and young infants who received a diagnosis of HPeV3 infection on the basis of real-time polymerase chain reaction analysis of serum and/or cerebrospinal fluid specimens at the National Center for Child Health and Development in Tokyo between November 2010 and September 2011. Results: Fifteen neonates and young infants were diagnosed as having HPeV3 infection; median age was 33 days (range: 10–81 days). The most common clinical presentation on admission was fever (80%), the median duration of which was 3 days (range: 1–4 days). Five (33%) children required admission to the intensive care unit for close observation, and 2 (13%) required mechanical ventilation for cardiovascular instability. After hospitalization, all children developed rash, mainly on the extremities, at a mean of 3 days (range: 1–5 days) after fever onset. The most striking finding was that 80% (12/15) of patients developed a distinctive palmar–plantar erythematous rash, which disappeared after a median of 3 days (range: 2–7 days). All patients were discharged from hospital without serious sequelae. Conclusions: Palmar–plantar erythema in febrile neonates and young infants may be a diagnostic clue of HPeV3 infection.

5 September 2012 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MSMai Sato
Mai Sato
SIShuichi Ito
Shuichi Ito
MOMasao Ogura
Masao Ogura
KKKoichi Kamei
Koichi Kamei
IMIsao Miyairi
Isao Miyairi
KMKentaro Matsuoka
Kentaro Matsuoka

25 January 2011 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
IMIppei Miyata
Ippei Miyata
HSHirokazu Saegusa
Hirokazu Saegusa
MSMichiro Sakurai
Michiro Sakurai

7 January 2019 in Human Genome Variation
Verified
Journal Article
Open access
PDF file
SOSahoko Ono
Sahoko Ono
JMJunko Matsuda
Junko Matsuda
EWEtsuko Watanabe
Etsuko Watanabe
HAHiroto Akaike
Hiroto Akaike
HTHideto Teranishi
Hideto Teranishi
KOKazunobu Ouchi
Kazunobu Ouchi
Biallelic mutations in the neuroblastoma amplified sequence (NBAS) gene have been reported to cause two different clinical spectra: short stature with optic nerve atrophy and Pelger-Huët anomaly (SOPH) syndrome and infantile liver failure syndrome 2 (ILFS2). Here, we describe a case of a 3-year-old Japanese boy who presented with fever-triggered recurrent acute liver failure (ALF). The clinical characteristics were considerable elevation of liver enzymes, severe coagulopathy, and acute renal failure. In addition to the liver phenotype, he had short stature and Pelger-Huët anomaly in the peripheral granulocytes. Whole-exome and Sanger sequencing of the patient and his parents revealed that he carried novel compound heterozygous missense mutations inNBAS, c.1018G>C (p.Gly340Arg) and c.2674 G>T (p.Val892Phe). Both mutations affect evolutionarily conserved amino acid residues and are predicted to be highly damaging. Immunoblot analysis of the patient’s skin fibroblasts showed a normal NBAS protein level but a reduced protein level of its interaction partner, p31, involved in Golgi-to-endoplasmic reticulum retrograde vesicular trafficking. We recommendNBASgene analysis in children with unexplained fever-triggered recurrent ALF or liver dysfunction. Early antipyretic therapy may prevent further episodes of ALF.

3 September 2012 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
KSKensuke Shoji
Kensuke Shoji
HKHisako Komuro
Hisako Komuro
YKYoshinori Kobayashi
Yoshinori Kobayashi
TSTatsuhiko Shike
Tatsuhiko Shike
TFTakanori Funaki
Takanori Funaki
ASAkihiko Saitoh
Akihiko Saitoh